Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study

Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics. In order to overcome this hurdle, liposomal encapsulation of the drug with differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Anam, Wang, Scarlet Xiaoyan, Ghali, Lucy, Bell, Celia, Wen, Xuesong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979440/
https://www.ncbi.nlm.nih.gov/pubmed/29617346
http://dx.doi.org/10.3390/ijms19041081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979440/
https://www.ncbi.nlm.nih.gov/pubmed/29617346
http://dx.doi.org/10.3390/ijms19041081

Ejemplares similares